Condition (MeSH)
Acute Disease
ClinicalTrials.gov lists 57 trials for Acute Disease or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
57 of the 57 trials are tagged with Acute Disease itself; the rest are tagged with a narrower condition beneath it.
When did Acute Disease trials start? (23)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
- Unknown
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 6 |
| 2025 | 5 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 4 |
| 2021 | 1 |
| 2020 | 5 |
| 2019 | 2 |
| 2018 | 4 |
| 2017 | 2 |
Showing 10 of 23 earlier years.
No forecast is made for this condition: it averages 3.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 22 months across 33 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Acute Disease trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 5 |
| Phase 2/3 | 1 |
| Phase 3 | 3 |
| Phase 4 | 3 |
| Not applicable | 22 |
| Observational | 22 |
| Unknown | 1 |
How many Acute Disease trials are recruiting? (9)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 8 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 2 |
| Completed | 28 |
Showing 5 of 9 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Acute Disease trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Pascoe Pharmazeutische Praeparate GmbH | 2 |
| Turku University Hospital | 2 |
| Antisoma Research | 1 |
| Becton, Dickinson and Company | 1 |
| Catalan Institute of Health | 1 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Acute Disease? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Vosaroxin | 1 |
| Vitamin C | 1 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Ertapeneme | 1 |
| Benzodiazepine | 1 |
| rhDNAse | 1 |
| Irrigation | 1 |
| AS1411 | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Acute Disease trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pneumonia | 27 | 1 |
| Febrile neutropenia | 24 | 1 |
| Stomatitis | 11 | 1 |
| Bacteraemia | 9 | 1 |
| Readmission | 9 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Acute Disease? (7,299)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis. | EBioMedicine | 2021 | Yes |
| Recovery of the Decline in Activities of Daily Living After Hospitalization Through an Individualized Exercise Program: Secondary Analysis of a Randomized Clinical Trial. | The journals of gerontology. Series A, Biological sciences and medical sciences | 2021 | Yes |
| Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable Resources. | Critical care medicine | 2021 | Yes |
| Effect of Whole-Genome Sequencing on the Clinical Management of Acutely Ill Infants With Suspected Genetic Disease: A Randomized Clinical Trial. | JAMA pediatrics | 2021 | Yes |
| Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide. | Developmental medicine and child neurology | 2020 | Yes |
Showing 5 of 7,299 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.